Evidence map›Paper›PMID 41134323›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2026

A pilot study of nectin-4-targeted radioligand [

Chunjuan Jiang, Miaoyan Wei, Panli Li, Silong Hu, Xiaoping Xu, Jindian Li, Dan Huang, Weiwei Weng, Xianjun Yu, Shaoli Song

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Prognostic value and diagnostic performance of nectin-4-targeted [European journal of nuclear medicine and molecular imaging · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Chunjuan Jiang *Department of Nuclear Medicine, Fudan University Shanghai Cancer Center, Shanghai, China.
Miaoyan Wei *Department of Oncology, Medical College, Fudan University, Shanghai, China.
Panli Li *Department of Nuclear Medicine, Fudan University Shanghai Cancer Center, Shanghai, China.
Silong HuDepartment of Nuclear Medicine, Fudan University Shanghai Cancer Center, Shanghai, China.
Xiaoping XuDepartment of Nuclear Medicine, Fudan University Shanghai Cancer Center, Shanghai, China.
Jindian LiDepartment of Nuclear Medicine, Fudan University Shanghai Cancer Center, Shanghai, China.
Dan HuangDepartment of Pathology, Shanghai Medical College, Fudan University, Shanghai, China.
Weiwei WengDepartment of Pathology, Shanghai Medical College, Fudan University, Shanghai, China.
Xianjun YuDepartment of Oncology, Medical College, Fudan University, Shanghai, China. yuxianjun@fudanpci.org.
Shaoli SongDepartment of Nuclear Medicine, Fudan University Shanghai Cancer Center, Shanghai, China. shaoli-song@163.com.ORCID 0000-0003-2544-7522

Funding

Key Program of National Natural Science Foundation of China U23A20465National Natural Science Foundation of China 82272035National Natural Science Foundation of China 82402331Shanghai Anticancer Association Program SACA-AX202316Shanghai Hospital Development Center SHDC 12023103Shanghai Scientific and Technological Innovation Program 23DZ2291400Shanghai Scientific and Technological Innovation Program 23TS1400800
6 · The paper itself

Abstract

purposeNectin-4 is highly expressed in pancreatic cancer. Accurate and quantitative measurements of Nectin-4 is useful for tumor diagnosis, treatment selection, and prognostic assessment. This study aimed to evaluate the diagnostic efficacy of a Nectin-4-targeted radioligand [

methodsThirty-three patients with PDAC were recruited and underwent head-to-head [

results[

conclusion[

Indexed as

Carcinoma, Pancreatic DuctalCell Adhesion MoleculesFluorodeoxyglucose F18Pancreatic NeoplasmsPositron Emission Tomography Computed TomographyAdultAgedAged, 80 and overFemaleGallium RadioisotopesHumansMaleMiddle AgedNectinsPilot ProjectsRadiopharmaceuticalsCell Adhesion MoleculesFluorodeoxyglucose F18Gallium-68Gallium RadioisotopesNECTIN4 protein, humanNectinsRadiopharmaceuticals

Identifiers

PMID41134323

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.